CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 507 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01472341
NCT01472341N/ACompleted

Beta-Cell Dysfunction and Insulin Resistance Among Italian Patients With Type 2 Diabetes

Merck Sharp & Dohme LLC·observational·Posted Nov 16, 2011·Updated Mar 10, 2017

In Brief

An observational study for Type 2 Diabetes. Completed, enrolled 507 participants.

Detailed Summary

The purpose of this study is to evaluate the degree of beta-cell dysfunction among participants with type 2 diabetes and the association between beta-cell dysfunction and demographic, clinical, and treatment variables.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
Countries--
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 16, 2011
Enrollment StartNov 1, 2008
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 14.6 years ago